Victoza Pancreatic Cancer

Diabetes Drug Victoza May Lead to Pancreatic Cancer in Some Users

The popular Type II diabetes drug Victoza, used by millions of Americans to regulate their blood glucose levels, has been linked to severe and life threatening pancreas problems. Researchers discovered a link between high rates of pancreatic cancer, acute pancreatitis and Victoza as early as 2013, yet many Americans have still not been adequately warned of the risk. Eleven other similar diabetes drugs are available that do not pose the level risk of Victoza pancreatitis and pancreatic cancer. Why, when Victoza poses greater risks than comparable diabetes drugs, has it become the leading drug of its type among U.S. consumers, garnering $2 billion in annual sales?

Critics say Novo Nordisk, the Danish multinational pharmaceutical conglomerate responsible for Victoza, has known of the risk for Victoza pancreatic cancer and acute pancreatitis and intentionally chose not to make the warning clear. In 2013, an FDA Victoza pancreas warning was released; evidence from a U.S. Justice Department case shows Novo Nordisk engaged in illegal and unethical marketing practices to obfuscate the warning. Marketing representatives urged and bribed physicians to use the drug despite the Victoza cancer connection, saying Victoza pancreas problems were not a serious concern and paying kickbacks for prescribing Victoza. Millions of Americans have been harmed as a result, at no fault of their own.

If you or someone you love experienced acute pancreatitis or pancreatic cancer from Victoza, you may be eligible to file a Victoza lawsuit against Novo Nordisk to recover damages for the pain, suffering, medical bills, and lost wages you have sustained. Our attorneys handling Victoza pancreatic cancer lawsuits believe that filing a claim is the only effective means for individual consumers to recover damages for the harm suffered as a result of this dangerous drug. Furthermore, often only the threat of major litigation can serve to motivate a company to become a better corporate citizen and place consumer safety ahead of sales goals.

Victoza Pancreatic Cancer

Scientific clinical studies have revealed an alarming link between Victoza and severe pancreas problems. By taking Victoza, consumers have unknowingly exposed themselves to a risk for acute pancreatitis and pancreatic cancer. Most alarming is the fact that eleven other Type II diabetes drugs have been shown to effectively regulate blood sugar levels without the dangerous pancreas risks of Victoza. Read full Victoza pancreatic cancer information to learn about Victoza pancreas risks and research.

FDA Victoza Warning

The FDA Victoza warning for pancreatitis and pancreatic cancer was released in 2013, yet many consumers still are unaware of the dangers posed by Victoza. Learn why the FDA Victoza warning has been largely ignored as Victoza has risen to its status as the most popular diabetes drug in its class. An FDA Victoza investigation has been ongoing since the drug was first approved in the United States. Read full FDA Victoza warning information for serious Victoza side effects.

Victoza Cancer Lawsuit

Our experienced team of Victoza lawyers is offering free, no-obligation Victoza lawsuit case review to persons who have been diagnosed with acute pancreatitis or pancreatic cancer from Victoza. Victoza lawsuit claims will serve to hold the company accountable for its efforts to downplay the risk of Victoza pancreatic cancer to physicians and the public.

Persons and the family members of persons who have experienced pancreas problems while taking Victoza may be eligible for real compensation through filing a Victoza lawsuit against Novo Nordisk. Contact our experienced product liability attorneys for a free Victoza lawsuit consultation. Read full Victoza lawsuit information that applies to claims nationwide.

Victoza Lawsuit FAQs

Offering general information on filing a Victoza lawsuit, this page offers frequently-asked questions and answers compiled by our attorney team handling Victoza lawsuit claims for plaintiffs nationwide. From Victoza lawsuit time limits to anticipated costs and fees, this page will answer your basic questions about filing a Victoza lawsuit. Should you wish to speak in depth with an attorney handling national Victoza lawsuit claims, please contact our firm through this site. We are currently offering free, no-obligation case reviews to persons and the family members of persons who have been harmed by Victoza and believe they may have grounds for filing a Victoza pancreas claim. Read full Victoza lawsuit questions and answers.

Victoza Lawyer

Our Victoza attorney team has a long track record of success when it comes to achieving justice on behalf of individuals harmed by dangerous drugs and large corporations. When a billion-dollar multinational pharmaceutical corporations is enjoying huge profits at the expense of public safety, our Victoza lawyers see it as their duty to pursue justice no matter how complex the case. Read full Victoza attorney information from one of the nation’s leading product liability law firms.

Victoza Pancreatic Cancer

Clinical studies have proven a link between Victoza and pancreas problems. The leading drug in its class of incretin mimetics, Victoza exposed patients to a heightened risk for pancreatic cancer and acute pancreatitis. Victoza pancreatitis and pancreatic cancer from Victoza are life-threatening conditions that many consumers know little about. This page provides detailed information about Victoza pancreatic cancer and acute pancreatitis, and the research behind the risks.

Victoza Diabetes Treatment

Victoza is widely-used treatment for Type II diabetes, serving to regulate blood sugar levels by prompting the pancreas to produce insulin. Without adequate insulin, diabetes can eventually suffer serious health conditions including blindness and kidney disease. While Victoza is effective at balancing blood sugar levels, it exposed patients to unnecessary risks for pancreatic cancer and acute pancreatitis.

Type II diabetes is a condition characterized by a lack of naturally-produced insulin, due to a lack of incretins such as Glucagon-Like Peptide-1 (GLP-1). Instead of injecting insulin directly, Victoza works by injecting a hormone known as an incretin mimetic, which mimics the effect of a natural incretin and stimulates the pancreas to produce insulin. The insulin the regulates the blood glucose level, resolving the dangerous imbalance. However, it is this emphasis on stimulating the pancreas which results in Victoza pancreas problems.

Victoza Risks

Since the very beginning, safety officials at the FDA have questioned whether Victoza pancreas risks are acceptable or not. Victoza pancreas problems were anticipated from the start, and several members of the drug application review committee were opposed to its approval. At that time, in January of 2010, Victoza was approved despite its risks, accompanied by an order to adopt a Risk Evaluation and Mitigation Strategy. Victoza acute pancreatitis and pancreatic cancer from Victoza have been under FDA investigation since. Today, the FDA does not recommend Victoza as a "first-line" diabetes therapy due to "several safety concerns", and drug safety experts point out that eleven other drugs are available that serve the same purpose without the corresponding Victoza pancreas risks.

Victoza Acute Pancreatitis

Clinical studies show that acute pancreatitis is 3.7 times more common in patients taking Victoza than those who are not. Acute pancreatitis from Victoza is a life-threatening condition that must be diagnosed rapidly in order to effective treatment to be administered to prevent tissue death, organ system failure, and even death from Victoza acute pancreatitis.

Patients suffering from Victoza pancreatitis may experience symptoms including debilitating abdominal pain and tenderness, fever, nausea, vomiting, sweating, clay-colored stools, bloating and indigestion, rapid heartbeat and breathing, and jaundice. These symptoms result from the sudden and rapid swelling and inflammation of the pancreas, which results in a loss of blood flow. The condition's rapid onset can quickly cause irreversible internal damage and may result in fatality.

Victoza Pancreatic Cancer

Studies comparing persons taking Victoza to others taking a placebo instead have found an alarming trend: Victoza pancreatic cancer is a real threat. Researchers suspected Victoza pancreas problems because the drug focuses on stimulating the pancreas to produce insulin. Two different studies have confirmed these findings.

The first Victoza pancreatic cancer study was published in February of 2013 in JAMA, the Journal of the American Medical Association. Researchers detected precancerous cells in the pancreas of many patients taking Victoza, prompting the FDA Victoza warning of 2013. The drug's warning label was amended to include new Victoza pancreas warnings yet the term "pancreatic cancer" was not specifically added, leaving American patients in the dark about the link between Victoza and pancreatic cancer.

In 2016, a second study was published, this one aimed at analyzing the degree of risk for pancreatic cancer from Victoza. Known as the LEADER clinical trial, the 2016 Victoza cancer study concluded that Victoza increased the risk for pancreatic cancer three-fold. In other words, three times as many people develop pancreatic cancer from Victoza than in the general population not taking the drug. This is a significant risk which has led some safety experts to question whether Victoza should still be in use.

Drugmaker Hid Victoza Pancreas Problems

Any drug that produces its results by stimulating the pancreas can be expected to cause some degree of pancreas problems, so research has focused on Victoza pancreatic cancer and acute pancreatitis from the start. The research has revealed that patients taking Victoza have a higher risk for pancreas problems that persons taking other incretin mimetics. It should then follow that patients would be warned and might choose a safer alternative. Yet Victoza, despite its pancreas problems, has become the top-selling drug in its class. How can that be?

Critics point to the fact that Novo Nordisk has already encountered legal trouble for its promotion of Victoza. In 2017, the Danish drugmaker paid $58 million to resolve a case with the U.S. Department of Justice over claims that the company paid illegal kickbacks to doctors for prescribing Victoza, and launched marketing campaigns aimed at downplaying the Victoza pancreatic cancer risk as unimportant. Plaintiffs in Victoza pancreas claims say this amounts to choosing profits over the safety of human beings.

Let Our Victoza Cancer Attorneys Help You

Our attorneys specialize in holding large corporations accountable when they've placed profits ahead of safety. Through settlements and winning verdicts, our attorneys have obtained millions for our clients. Let us help you today.

Victoza Lawsuits for Acute Pancreatitis

Filing a lawsuit will allow you to hold the pharmaceutical company accountable for damage it has caused you or a loved one, while also providing real compensation for your medical expenses, suffering and loss. Contact us today for a free consultation.

FDA Victoza Warning

From the very beginning, when Victoza was first up for approval as a new treatment for Type II diabetes, safety experts at the FDA questioned the safety of Victoza.The FDA Victoza warning, released in 2013, confirmed suspicions that Victoza posed a risk to consumers for serious and life-threatening pancreas problems. However, it has taken years for the FDA Victoza warning to become widely known among consumers and the medical community. This page provide comprehensive information on the FDA Victoza warning as well as the ongoing FDA investigation into Victoza pancreas problems.

While the first official FDA Victoza warning was not issued until 2013, we now know that safety experts within the federal agency were concerned about Victoza risks from the beginning. Novo Nordisk submitted an application to the FDA to have Victoza approved as a blood-glucose regulator 2010, a new incretin mimetic for treatment of persons suffering from Type II diabetes. Because incretin mimetics operate by stimulating the pancreas, this type of drug is prone to causing pancreas problems. At the time of its approval, three FDA safety experts expressed a view that Victoza risks outweigh its benefits. The drug was approved against their wishes, with a requirement to continue monitoring outcomes and testing the safety of the drug.

An official FDA Victoza warning was issued in 2013, prompted by the release of study findings which linked Victoza to pancreatic cancer and acute pancreatitis. Published in JAMA, the study detected a trend of precancerous cell growth in the pancreases of persons taking Victoza. A higher-than-normal rate of acute pancreatitis was also revealed in this study. The FDA Victoza warning cautioned doctors and patients alike that Victoza pancreas problems could be severe and life-threatening, requiring immediate medical attention.

FDA Victoza Warning for Acute Pancreatitis

The potential for developing acute pancreatitis from Victoza is detailed in the FDA Victoza warning. A diagnosis of acute pancreatitis is an emergency condition that requires swift medical attention. Characterized by pancreatic swelling and inflammation, acute pancreatiti cuts off the organ’s blood supply and can lead to tissue death, organ system failure, and even fatality. Because of the risk of acute pancreatitis, the FDA Victoza warning states the drug is not appropriate as a first-tier treatment for Type II diabetes but should only be used as an alternative to other, safer treatments.

Victoza Cancer Warning

Just three years after Victoza was first approved by the FDA, a study was published in JAMA which revealed evidence of a link between Victoza and pancreatic cancer. This finding was followed up by a detailed clinical trial known as LEADER which found thataking t Victoza resulted in a three-fold increased risk for pancreatic cancer. The danger of Victoza pancreatic cancer is still not specifically listed on the drug’s label and many consumers using the Victoza for blood sugar regulation are unaware of the danger.

Illegal Marketing Combats FDA Victoza Warning

Pancreatic cancer and acute pancreatitis were listed as potential side effects in the 2013 FDA Victoza warning, yet many patients and doctors have not heeded the warning. Critics point to two reasons for this: first, Novo Nordisk, along with other pharmaceutical companies selling similar drugs, faced a major Department of Justice lawsuit during 2017 for using illegal marketing tactics to downplay Victoza dangers and promote the drug to doctors. The company paid $58 million to resolve these claims. Secondly, the drug’s warning label does not include the term “pancreatic cancer”. Doctors were told the warning was untrue or not a serious risk; simultaneously some physicians were paid kickbacks for favoring Victoza over other (safer) drugs. Victoza rose to prominence as the best-selling drug in its class, bringing in more than $2 billion in 2014 sales alone.

Let Our Victoza Attorneys Help You

Our lawyers specialize in holding large corporations accountable when they've placed profits ahead of safety. Through settlements and winning verdicts, our attorneys have obtained millions for our clients. Let us help you today.

Victoza Lawsuit

Filing a lawsuit will allow you to hold the pharmaceutical company accountable for damage it has caused you or a loved one, while also providing real compensation for your medical expenses, suffering and loss. Contact us today for a free consultation.

If you or a member of your family has suffered from acute pancreatitis or pancreatic cancer from Victoza, you may have grounds to file a Victoza lawsuit to recover damages. Victoza lawsuit claims filed against Novo Nordisk, the Denmark-based multinational pharmaceutical conglomerate, is the only means for individuals and families harmed by Victoza to obtain compensation for the harm and suffering they have encountered as a result of this dangerous drug.

Novo Nordisk officials knew of the risks posed by Victoza yet launched marketing campaigns aimed at promoting the drug to its current status as best-seller in its class. As the top-selling incretin mimetic worldwide, Victoza garnered $2 billion in sales in 2014 alone. At times, the company engaged in illegal marketing practices to build this Victoza’s market dominance, paying kickbacks to doctors who prescribed Victoza and downplaying the Victoza cancer risk, according to a 2017 Department of Justice Victoza lawsuit.

The company paid $58 million to resolve these claims, but many Americans are still unaware of the Victoza pancreatic cancer risk. Since Victoza was approved in 2010, millions of Americans have unknowingly been exposed to a danger of developing severe and life-threatening pancreas problems as a result of the company’s actions, and many thousands have experienced suffering and harm at no fault of their own. Today, countless Americans are filing Victoza lawsuit claims against Novo Nordisk, both to hold the company to task for its implorable actions, and to obtain the compensation they deserve for medical bills, pain, suffering, and lost wages.

Victoza Pancreatic Cancer Lawsuits

If you or a loved one experienced pancreas problems while taking Victoza, you may be eligible to obtain compensation for associated medical expenses, lost time at work, pain, suffering and loss through filing a Victoza lawsuit. Representing clients based anywhere in the country, our attorney handling Victoza lawsuit claims are offering no-obligation Victoza lawsuit case review at no cost. To discuss your situation in detail with an experienced product liability lawyer and to learn about Victoza lawsuit time limits in your state, please complete our online contact form. One of our attorneys handling Victoza lawsuits for pancreatitis and pancreatic cancer will contact you promptly.

Victoza Lawsuits Are Not Class Action Lawsuits

If you are wondering whether it is really worth is to file a Victoza lawsuit for pancreatic cancer or acute pancreatitis, you are not alone. This concern is one we hear frequently from our potential clients, because many people assume filing a Victoza lawsuit will occur as part of a large class action claim. On the contrary, we anticipate that successful Victoza lawsuit claims with result in significant compensation for the persons and families involved, due to the very grave nature of these cases. While many serious product liability claims are consolidated as multidistrict litigation (MDL), the unique details of each case is preserved and the compensation is real - not symbolic.

Victoza Lawsuits: No Fees Unless We Collect for You

Our attorneys never charge legal fees unless we win compensation in your case because we are committed to representing all persons involved in a Victoza lawsuit for pancreatic cancer or acute pancreatitis on a contingency basis. To receive a no-cost, no-obligation consultation please fill out our short online contact form and one of our lawyers handling Victoza lawsuits will contact you to answer any of your questions.

No-Cost, No-Obligation Victoza Lawsuit Case Review If You or a Loved One Developed Pancreas Problems

The Onder Law Firm is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm won $197 million in three talcum powder ovarian cancer lawsuits in St. Louis in 2016 and other law firms throughout the nation often seek its experience and expertise on complex litigation.

Victoza Lawyers

Our Victoza attorneys believe that anyone who has experienced acute pancreatitis or suffered from pancreatic cancer as a result of taking Victoza may be entitled to real and significant compensation. Our experienced team of Victoza lawyers is now offering free, no-obligation case reviews to individuals who believe they may have a claim. Filing a claim against Novo Nordisk is the only means to recover damages for the medical expenses, loss, and suffering resulting from Victoza pancreatic cancer or acute pancreatitis.

Evidence suggests Novo Nordisk officials knew of the risk of pancreas problems from Victoza yet chose not to warn consumers. The company even went so far as to engage in illegal marketing practices to minimize the risk of pancreatic cancer and bolster Victoza sales, according to legal documents from a recent Justice Department lawsuit. Victoza earned Novo Nordisk over $2 billion in annual sales in 2014 alone. This type of situation is all too common among billion-dollar pharmaceutical conglomerates, and it is the mission of our Victoza lawyer team to hold pharmaceutical companies accountable for the harm they cause.

The Victoza lawyers at The Onder Law Firm have a proven track record in the area of product liability litigation related to dangerous drugs and defective medical devices, winning major compensation for families harmed by large corporations. Representing families nationwide, our Victoza attorneys have seen the aftermath of major drug recalls. We are aware of the very serious nature of pancreatic cancer and acute pancreatitis claims, medical conditions which can take a loved one away too soon or lead to a family's financial ruin. Our objective is to pursue justice no matter how complex the case. To that end, our firm is dedicating its significant resources to providing the premier Victoza lawyer representation for persons and families who have been harmed by this dangerous drug.

No Fees Unless We Collect for You - Our Victoza Attorneys Provide Representation on Contingency

The Onder Law Firm's Victoza attorneys for pancreatic cancer and acute pancreatitis claims are committed to providing representation on a contingency basis, meaning we never charge a fee unless we win compensation on your behalf. Persons and family members of persons who were diagnosed with acute pancreatitis or developed pancreatic cancer and have a history of taking Victoza qualify to receive a free, no-obligation case review from an expert Victoza lawyer. Simply contact our firm using this site’s contact form or online chat feature and one of our Victoza pancreatic cancer lawyers will contact you promptly to discuss your case in detail.

Victoza Attorneys Help Families

Our Victoza attorneys representing individuals and families in pancreatic cancer and acute pancreatitis claims believe that filing a lawsuit against Novo Nordisk is the only effective means to obtain compensation for damages caused. Furthermore, by filing a claim with a Victoza attorney consumers can bring attention to the company's unethical handling of Victoza and exert pressure over Novo Nordisk to place a greater emphasis on drug safety in the future. If you or a loved one have experienced pancreas problems from Victoza, you are eligible for a free, no-obligation Victoza attorney case review.

The Onder Law Firm

The Onder Law Firm is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.